September 4, 2026 |
Tyson Foods, Inc. (TSN)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tyson Foods, Inc. (“Tyson Foods” or “the Company”) (NYSE: TSN). Investors who purchased Tyson Foods securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
September 4, 2026 |
FuelCell Energy, Inc. (FCEL)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FuelCell Energy, Inc. (“FuelCell” or “the Company”) (NASDAQ: FCEL). Investors who purchased FuelCell securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 4, 2026 |
Guggenheim Strategic Opportunities Fund (GOF)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Guggenheim Strategic Opportunities Fund (“Guggenheim” or “the Company”) (NYSE: GOF). Investors who purchased Guggenheim securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
September 3, 2026 |
XTI Aerospace, Inc. (XTIA)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XTI Aerospace, Inc. (“XTI Aerospace” or “the Company”) (NASDAQ: XTIA). Investors who purchased XTI Aerospace securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
September 2, 2026 |
Insulet Corporation (PODD)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insulet Corporation (“Insulet Corporation” or “the Company”) (NASDAQ: PODD). Investors who purchased Insulet Corporation securities prior to May 21, 2026, and continue to hold to the present, are… read more
September 2, 2026 |
D-Wave Quantum Inc. (QBTS)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. (“D-Wave” or “the Company”) (NASDAQ: QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 1, 2026 |
SELLAS Life Sciences Group, Inc. (SLS)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SELLAS Life Sciences Group, Inc. (“SELLAS” or “the Company”) (NASDAQ: SLS). Investors who purchased SELLAS securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
August 31, 2026 |
Hub Group, Inc. (HUBG)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hub Group, Inc. (“Hub Group” or “the Company”) (NASDAQ: HUBG). Investors who purchased Hub Group securities prior to April 28, 2023, and continue to hold to the present,… read more
August 27, 2026 |
Qfin Holdings, Inc. (QFIN)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Qfin Holdings, Inc. (“Qfin” or “the Company”) (NASDAQ: QFIN). Investors who purchased Qfin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 27, 2026 |
Qfin Holdings, Inc. (WFIN)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Qfin Holdings, Inc. (“Qfin” or “the Company”) (NASDAQ: WFIN). Investors who purchased Qfin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 26, 2026 |
LENZ Therapeutics, Inc. (LENZ)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LENZ Therapeutics, Inc. (“LENZ” or “the Company”) (NASDAQ: LENZ). Investors who purchased LENZ securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 26, 2026 |
OSI Systems, Inc. (OSIS)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OSI Systems, Inc. (“OSI” or “the Company”) (NASDAQ: OSIS). Investors who purchased OSI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 26, 2026 |
Peabody Energy Corporation (BTU)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Peabody Energy Corporation (“Peabody” or “the Company”) (NASDAQ: BTU). Investors who purchased Peabody securities prior to October 14, 2024, and continue to hold to the present, are encouraged… read more
August 26, 2026 |
testpublication2 (testpublication2)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of testpublication2 (“testpublication2” or “the Company”) (NASDAQ: TESTPUBLICATION2). Investors who purchased testpublication2 securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether testpublication2 has… read more
August 23, 2026 |
Barclays PLC (BCS)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barclays PLC (“Barclays” or “the Company”) (NYSE: BCS). Investors who purchased Barclays securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Barclays… read more
August 21, 2026 |
L3Harris Technologies, Inc. (LHX)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of L3Harris Technologies, Inc. (“L3Harris” or “the Company”) (NYSE: LHX). Investors who purchased L3Harris securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 21, 2026 |
Klarna Group plc (KLAR)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Klarna Group plc (“Klarna” or “the Company”) (NYSE: KLAR). Investors who purchased Klarna securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 21, 2026 |
Criteo S.A. (CRTO)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Criteo S.A. (“Criteo” or “the Company”) (NASDAQ: CRTO). Investors who purchased Criteo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Criteo… read more
August 21, 2026 |
Baidu, Inc. (BIDU)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Baidu, Inc. (“Baidu” or “the Company”) (NASDAQ: BIDU). Investors who purchased Baidu securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Baidu… read more
August 20, 2026 |
Caesars Entertainment, Inc. (CZR)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating claims on behalf of investors in Caesars Entertainment, Inc. (“Caesars” or “the Company”) (NASDAQ: CZR) for potential breaches of fiduciary duty on the part of its directors and management. Investors who purchased Caesars and continue to… read more
August 19, 2026 |
Emergent BioSolutions Inc. (EBS)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Emergent BioSolutions Inc. (“Emergent” or “the Company”) (NYSE: EBS). Investors who purchased Emergent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 19, 2026 |
Embecta Corp. (EMBC)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Embecta Corp. (“Embecta” or “the Company”) (NASDAQ: EMBC). Investors who purchased Embecta securities prior to November 25, 2026, and continue to hold to the present, are encouraged to… read more
August 19, 2026 |
Black Rock Coffee Bar, Inc. (BRCB)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or “the Company”) (NASDAQ: BRCB). Investors who purchased Black Rock Coffee securities prior to September 12, 2025, and continue to… read more
August 18, 2026 |
Sionna Therapeutics, Inc. (SION)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sionna Therapeutics, Inc. (“Sionna” or “the Company”) (NASDAQ: SION). Investors who purchased Sionna securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 18, 2026 |
Lincoln Educational Services Corp. (LINC)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lincoln Educational Services Corp. (“Lincoln Educational” or “the Company”) (NASDAQ: LINC). Investors who purchased Lincoln Educational securities are encouraged to obtain additional information and assist the investigation. The… read more
August 17, 2026 |
Erasca, Inc. (ERAS)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Erasca, Inc. (“Erasca” or “the Company”) (NASDAQ: ERAS). Investors who purchased Erasca securities prior to January 14, 2025, and continue to hold to the present, are encouraged to… read more
August 17, 2026 |
Via Transportation, Inc. (VIA)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Via Transportation, Inc. (“Via Transportation” or “the Company”) (NYSE: VIA). Investors who purchased Via Transportation securities prior to September 12, 2025, and continue to hold to the present,… read more
August 13, 2026 |
CVRx, Inc. (CVRX)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX). Investors who purchased CVRx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CVRx… read more
August 7, 2026 |
Honeywell Aerospace, Inc. (HONA)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Honeywell Aerospace, Inc. (“Honeywell Aerospace” or “the Company”) (NASDAQ: HONA). Investors who purchased Honeywell Aerospace securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
August 6, 2026 |
BitGo Holdings, Inc. (BTGO)
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BitGo Holdings, Inc. (“BitGo” or “the Company”) (NYSE: BTGO). Investors who purchased BitGo securities prior to January 22, 2025, and continue to hold to the present, are encouraged… read more